Shardul Amarchand Mangaldas & Co advises Evonile Pharma Ltd. on acquisition of ‘Minipress’ and ‘Minipres’ brands from Pfizer
SAM advised Evonile Pharma Limited on all aspects of the transaction.
pharmaceutical industry
Drugs (Prices Control) Amendment Order, 2026: Key Changes in Drug Pricing, Price Revision, New Drug Launch and Compliance
The Ministry of Chemicals and Fertilizers has notified the Drugs (Prices Control) Amendment Order, 2026, introducing changes relating to drug pricing, overcharging, launch of new drugs, price revision and record maintenance under the Drugs (Prices Control) Order, 2013.